Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia
J. Marin Corral (Barcelona, Spain), S. Pascual Guardia (Barcelona, Spain), F. Amati (Milan, Italy), S. Aliberti (Milan, Italy), J. Masclans (Barcelona, Spain), N. Soni (San Antonio, United States of America), A. Rodriguez (Tarragona, Spain), O. Sbila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), A. Anzueto (San Antonio, United States of America), K. Dimakou (Athens, Greece), M. Medenica (Niksic), R. Petrino (Vercelly, Italy), E. Van De Garde (Nieuwegein, Netherlands), M. Restrepo (San Antonio, United States of America)
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Marin Corral (Barcelona, Spain), S. Pascual Guardia (Barcelona, Spain), F. Amati (Milan, Italy), S. Aliberti (Milan, Italy), J. Masclans (Barcelona, Spain), N. Soni (San Antonio, United States of America), A. Rodriguez (Tarragona, Spain), O. Sbila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), A. Anzueto (San Antonio, United States of America), K. Dimakou (Athens, Greece), M. Medenica (Niksic), R. Petrino (Vercelly, Italy), E. Van De Garde (Nieuwegein, Netherlands), M. Restrepo (San Antonio, United States of America). Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia. 3104
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: